Free Webinar on U.S. Market Access for Pharmaceutical Companies
Japan Pharmaceutical & BioScience Society (Japan PBSS) will host a free online webinar titled 'What is Market Access? Essential Knowledge and Preparation for Launching Pharmaceuticals in the U.S.' on July 25, 2026 (Sat), from 8:00 to 9:00 JST. The event aims to support Japanese companies entering the U.S. market by providing practical insights to overcome revenue delays post-FDA approval.
📋 Article Processing Timeline
- 📰 Published: June 15, 2026 at 22:00
- 🔍 Collected: June 16, 2026 at 00:06 (2h 6m after Published)
- 🤖 AI Analyzed: June 16, 2026 at 00:12 (5 min after Collected)
The Japan Pharmaceutical & BioScience Society (Japan PBSS), a non-profit organization, will host a free online webinar titled 'What is Market Access? Essential Knowledge and Preparation for Launching Pharmaceuticals in the U.S.' on Saturday, July 25, 2026, from 8:00 to 9:00 JST.
The U.S. healthcare system and insurance reimbursement structure differ significantly from Japan’s. While Japanese companies are increasingly expanding into the U.S. market with pharmaceutical and biotech products, many face delayed commercialization after FDA approval due to insufficient understanding of Market Access. This webinar will clearly explain, with real-world examples, what preparations are needed and when they should be made for a successful U.S. market launch.
## Event Overview
Title: What is Market Access? Essential Knowledge and Preparation for Launching Pharmaceuticals in the U.S.
Date and Time: July 25, 2026 (Sat), 8:00–9:00 JST
Format: Online (via Zoom)
Participation Fee: Free
Registration Page: https://www.pbss.org/eventDetails/1064
## Speaker
Aiko Kato (CEO, RykoTECH)
A strategist based in Boston with over nine years of deep involvement in the biotech and deep-tech startup ecosystem. She specializes in cross-border business development and investment strategies between Japan and the U.S. Combining perspectives as a scientist, investor, startup founder, and entrepreneur, she has extensive experience in launching Japanese corporate venture capital (CVC) funds, portfolio strategy, technology scouting, and startup support. She collaborates with government agencies such as AMED, MEDISO, and JETRO to support Japanese companies’ overseas expansion. Through community initiatives like PBSS, she serves as a hub for Boston’s local network.
## Key Topics of the Webinar
- What is the 'Market Access barrier' that companies face after FDA approval?
- Understanding the U.S. insurance reimbursement system and stakeholder landscape
- Market launch preparation timeline: What to prepare and when
- Common pitfalls for Japanese companies based on past success and failure cases
- Strategic perspectives for Japanese companies competing in the U.S. market
## Media Coverage and Article Publication Guidelines
This event is operated as a semi-closed session, prioritizing a safe environment where speakers and participants can freely exchange opinions. We kindly request your cooperation in the following:
- Please contact us separately if you wish to cover or report on this event or organization.
- When publishing articles, please ensure that speakers’ presentations or participants’ comments are not identifiable.
- Please refrain from photographing, recording, or audio/video taping the event. If needed for reporting, please contact us in advance.
## Organization Overview
Japan PBSS is a professional community in the pharmaceutical and bioscience fields, promoting knowledge exchange across diverse areas such as R&D, regulatory affairs, data science, and business development. Through webinars and study groups, the organization aims to share the latest domestic and international insights and contribute to industry advancement.
Official Name: Japan Pharmaceutical & BioScience Society (Japan PBSS)
Established: July 2025
Mission: Strengthening Japan’s drug discovery capabilities through knowledge circulation
Activities: Seminars, workshops, networking, industry-academia collaboration support, international exchange, etc.
Website: https://www.pbss.org/chapter/Japan
LinkedIn: https://www.linkedin.com/company/japan-pharmaceutical-bioscience-society/
Official Note: https://note.com/japan_pbss
Contact: info.japan@pbss.org
Staff: Sugita, Ikeda, Kurokasa
The U.S. healthcare system and insurance reimbursement structure differ significantly from Japan’s. While Japanese companies are increasingly expanding into the U.S. market with pharmaceutical and biotech products, many face delayed commercialization after FDA approval due to insufficient understanding of Market Access. This webinar will clearly explain, with real-world examples, what preparations are needed and when they should be made for a successful U.S. market launch.
## Event Overview
Title: What is Market Access? Essential Knowledge and Preparation for Launching Pharmaceuticals in the U.S.
Date and Time: July 25, 2026 (Sat), 8:00–9:00 JST
Format: Online (via Zoom)
Participation Fee: Free
Registration Page: https://www.pbss.org/eventDetails/1064
## Speaker
Aiko Kato (CEO, RykoTECH)
A strategist based in Boston with over nine years of deep involvement in the biotech and deep-tech startup ecosystem. She specializes in cross-border business development and investment strategies between Japan and the U.S. Combining perspectives as a scientist, investor, startup founder, and entrepreneur, she has extensive experience in launching Japanese corporate venture capital (CVC) funds, portfolio strategy, technology scouting, and startup support. She collaborates with government agencies such as AMED, MEDISO, and JETRO to support Japanese companies’ overseas expansion. Through community initiatives like PBSS, she serves as a hub for Boston’s local network.
## Key Topics of the Webinar
- What is the 'Market Access barrier' that companies face after FDA approval?
- Understanding the U.S. insurance reimbursement system and stakeholder landscape
- Market launch preparation timeline: What to prepare and when
- Common pitfalls for Japanese companies based on past success and failure cases
- Strategic perspectives for Japanese companies competing in the U.S. market
## Media Coverage and Article Publication Guidelines
This event is operated as a semi-closed session, prioritizing a safe environment where speakers and participants can freely exchange opinions. We kindly request your cooperation in the following:
- Please contact us separately if you wish to cover or report on this event or organization.
- When publishing articles, please ensure that speakers’ presentations or participants’ comments are not identifiable.
- Please refrain from photographing, recording, or audio/video taping the event. If needed for reporting, please contact us in advance.
## Organization Overview
Japan PBSS is a professional community in the pharmaceutical and bioscience fields, promoting knowledge exchange across diverse areas such as R&D, regulatory affairs, data science, and business development. Through webinars and study groups, the organization aims to share the latest domestic and international insights and contribute to industry advancement.
Official Name: Japan Pharmaceutical & BioScience Society (Japan PBSS)
Established: July 2025
Mission: Strengthening Japan’s drug discovery capabilities through knowledge circulation
Activities: Seminars, workshops, networking, industry-academia collaboration support, international exchange, etc.
Website: https://www.pbss.org/chapter/Japan
LinkedIn: https://www.linkedin.com/company/japan-pharmaceutical-bioscience-society/
Official Note: https://note.com/japan_pbss
Contact: info.japan@pbss.org
Staff: Sugita, Ikeda, Kurokasa
FAQ
How can I join this webinar?
Register for free via the official website. The Zoom link will be sent to registrants.
What exactly is Market Access?
It’s the strategy to ensure a drug is covered by insurance and adopted by providers and patients.
Is this suitable for beginners?
Yes, technical terms are clearly explained, making it accessible to newcomers.